Eupraxia Pharmaceuticals (EPRX) Receivables - Net (2023 - 2025)
Eupraxia Pharmaceuticals' Receivables - Net came in at $716,095 for the quarter ended Dec 31, 2025, up 177.5% from $258,074 a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Receivables - Net (2023 - 2025) Analysis & Trends
- Going back by year, Receivables - Net was $258,074 in the year ended Dec 31, 2024 (+67.9%) and $153,749 in the year ended Dec 31, 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.26 Bn | 1,105.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 618.12 Bn | 536.65 Bn | 17.26 Bn |
| 3 | AbbVie | 503.25 Bn | 476.36 Bn | 12.70 Bn |
| 4 | Merck | 368.28 Bn | 322.66 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.45 Bn | 262.44 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.39 Bn | 235.08 Bn | 12.86 Bn |
| 7 | Amgen | 237.30 Bn | 192.70 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.35 Bn | 165.55 Bn | 6.22 Bn |
| 9 | Pfizer | 169.92 Bn | 116.56 Bn | 10.94 Bn |
| 10 | Eupraxia Pharmaceuticals | 306.86 Mn | -135.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 716,095.00 |
| Dec 31, 2024 | 258,074.00 |
| Dec 31, 2023 | 153,749.00 |
API Access
Eupraxia Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();